Index RUT
P/E -
EPS (ttm) -0.13
Insider Own 5.05%
Shs Outstand 181.25M
Perf Week 3.28%
Market Cap 325.33M
Forward P/E -
EPS next Y -0.07
Insider Trans -0.99%
Shs Float 175.94M
Perf Month -13.08%
Income -24.06M
PEG -
EPS next Q -0.03
Inst Own 75.99%
Short Float 3.77%
Perf Quarter -6.11%
Sales 169.98M
P/S 1.91
EPS this Y 38.10%
Inst Trans 2.14%
Short Ratio 6.73
Perf Half Y -6.11%
Book/sh 0.27
P/B 6.57
EPS next Y 46.15%
ROA -12.52%
Short Interest 6.63M
Perf Year 31.02%
Cash/sh 0.38
P/C 4.57
EPS next 5Y -
ROE -47.96%
52W Range 1.21 - 2.59
Perf YTD -18.72%
Dividend Est. -
P/FCF -
EPS past 5Y 13.81%
ROI -18.91%
52W High -32.08%
Beta 1.19
Dividend TTM -
Quick Ratio 1.83
Sales past 5Y 16.80%
Gross Margin 54.75%
52W Low 45.70%
ATR (14) 0.09
Dividend Ex-Date -
Current Ratio 2.51
EPS Y/Y TTM 53.83%
Oper. Margin -22.95%
RSI (14) 39.02
Volatility 4.51% 4.60%
Employees 288
Debt/Eq 1.99
Sales Y/Y TTM 10.79%
Profit Margin -14.15%
Recom 1.67
Target Price 4.50
Option/Short Yes / Yes
LT Debt/Eq 1.57
EPS Q/Q 57.55%
Payout -
Rel Volume 1.01
Prev Close 1.72
Sales Surprise 6.06%
EPS Surprise 28.57%
Sales Q/Q 16.02%
Earnings Aug 01 AMC
Avg Volume 986.12K
Price 1.76
SMA20 -3.71%
SMA50 -14.09%
SMA200 -11.11%
Trades
Volume 817,731
Change 2.08%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-12-24 Initiated
Craig Hallum
Buy
$5
Jan-20-23 Downgrade
BTIG Research
Buy → Neutral
Jan-17-23 Downgrade
Stephens
Overweight → Equal-Weight
$3.75
Oct-08-20 Resumed
BTIG Research
Buy
$9
Jun-16-20 Resumed
Cantor Fitzgerald
Overweight
$9
Feb-26-20 Initiated
BTIG Research
Buy
$7
Nov-13-19 Upgrade
BTIG Research
Neutral → Buy
$7
Aug-28-19 Initiated
Stifel
Buy
Aug-23-19 Resumed
Stephens
Overweight
Jan-05-18 Resumed
Cantor Fitzgerald
Overweight
Dec-08-17 Resumed
BTIG Research
Neutral
Jul-07-16 Resumed
Cantor Fitzgerald
Buy
$9
Dec-17-15 Downgrade
Wedbush
Outperform → Neutral
May-02-14 Reiterated
MLV & Co
Buy
$8.50 → $6
Apr-24-13 Reiterated
Cantor Fitzgerald
Buy
$5.50 → $6
Mar-15-13 Reiterated
MLV & Co
Buy
$7.50 → $8.50
Apr-17-12 Initiated
Cantor Fitzgerald
Buy
$5.50
Feb-29-12 Upgrade
Robert W. Baird
Neutral → Outperform
$3 → $6
Nov-10-11 Reiterated
MLV & Co
Buy
$4 → $5
Jun-03-11 Initiated
Wedbush
Outperform
$4
Show Previous Ratings
Sep-06-24 01:47AM
Aug-01-24 05:10PM
04:07PM
(Associated Press Finance)
04:00PM
Jul-18-24 08:30AM
04:00PM
Loading…
Jul-02-24 04:00PM
Jun-21-24 08:30AM
Jun-14-24 08:30AM
May-22-24 08:30AM
May-03-24 10:40AM
06:48AM
(Thomson Reuters StreetEvents)
03:58AM
May-02-24 08:59PM
06:04PM
04:04PM
(Associated Press Finance)
04:00PM
Loading…
04:00PM
Apr-18-24 08:30AM
Mar-26-24 08:30AM
Mar-19-24 08:00AM
Mar-15-24 01:49AM
01:48AM
Mar-07-24 01:40PM
11:46AM
Mar-06-24 06:23AM
(Thomson Reuters StreetEvents) +21.61%
Mar-05-24 09:53PM
04:26PM
(Associated Press Finance)
04:00PM
Feb-23-24 11:56AM
Feb-20-24 08:30AM
Feb-01-24 08:30AM
09:30AM
Loading…
Jan-15-24 09:30AM
Jan-08-24 08:30AM
Nov-03-23 09:19AM
08:30AM
Nov-02-23 06:43PM
05:25PM
04:20PM
(Associated Press Finance)
04:00PM
Oct-19-23 08:30AM
Oct-10-23 08:30AM
Sep-27-23 08:30AM
Sep-12-23 08:30AM
Aug-02-23 05:15PM
04:11PM
(Associated Press Finance)
04:00PM
Jul-31-23 12:36PM
Jul-19-23 08:30AM
Jul-03-23 05:13PM
Jun-15-23 08:30AM
Jun-14-23 08:30AM
Jun-07-23 10:30AM
Jun-05-23 08:30AM
May-30-23 07:16AM
May-04-23 05:15PM
04:10PM
04:00PM
May-02-23 12:25PM
Apr-20-23 08:30AM
Apr-18-23 10:54AM
Mar-10-23 09:24AM
Mar-09-23 11:45AM
Feb-28-23 04:00PM
Feb-21-23 11:00AM
Feb-15-23 08:30AM
Feb-10-23 08:30AM
Jan-19-23 11:45AM
Jan-09-23 08:30AM
Dec-21-22 05:50AM
Nov-09-22 05:58AM
Nov-04-22 08:00AM
Nov-03-22 05:55PM
04:00PM
Nov-02-22 01:52PM
Nov-01-22 08:00AM
Oct-20-22 08:30AM
Sep-26-22 08:00AM
Sep-21-22 09:35AM
Sep-14-22 11:55AM
Sep-13-22 11:17AM
Aug-29-22 09:35AM
Aug-24-22 07:58AM
Aug-12-22 08:00AM
Aug-05-22 01:00PM
Aug-04-22 05:25PM
04:00PM
Jul-28-22 09:48AM
Jul-21-22 08:00AM
Jul-14-22 12:00PM
06:25AM
Jul-13-22 11:37AM
Jul-05-22 05:00PM
Jun-23-22 09:55AM
Jun-14-22 08:00AM
Jun-03-22 09:55AM
May-17-22 05:00AM
May-16-22 09:55AM
May-15-22 08:42AM
May-06-22 02:30AM
May-05-22 05:15PM
04:00PM
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Green Kevin Dennis Chief Financial Officer Sep 04 '24 Sale 2.15 54,272 116,826 536,093 Sep 05 05:05 PM Green Kevin Dennis Chief Financial Officer Sep 03 '24 Sale 2.18 28,385 61,919 590,365 Sep 05 05:05 PM KEVIN D GREEN Officer Sep 04 '24 Proposed Sale 2.15 54,272 116,826 Sep 04 04:14 PM KEVIN D GREEN Officer Sep 03 '24 Proposed Sale 2.18 28,385 61,919 Sep 03 04:28 PM Jensen Chrystal Chief Legal Officer Aug 15 '24 Sale 2.06 16,667 34,417 474,245 Aug 19 04:35 PM CHRYSTAL NIKOLE JENSEN Officer Aug 15 '24 Proposed Sale 2.07 16,667 34,427 Aug 15 04:41 PM Benjamin Richard J Chief Medical Officer Aug 02 '24 Sale 2.50 21,605 54,012 438,007 Aug 07 04:07 PM RICHARD J BENJAMIN Officer Aug 02 '24 Proposed Sale 2.50 21,605 54,012 Aug 02 04:09 PM Shan Hua Director May 13 '24 Buy 1.99 2,500 4,975 32,386 May 14 06:30 PM NACHTSHEIM JAMI K Director May 10 '24 Buy 1.79 2,000 3,578 108,362 May 13 05:09 PM Witney Frank Director May 09 '24 Buy 1.89 20,000 37,800 180,059 May 10 08:17 PM Swisher Daniel N JR Director May 09 '24 Buy 1.88 2,500 4,689 107,045 May 09 05:15 PM Green Kevin Dennis Chief Financial Officer Mar 14 '24 Sale 1.97 21,497 42,444 618,750 Mar 14 09:53 PM Green Kevin Dennis Chief Financial Officer Mar 13 '24 Sale 2.02 21,058 42,438 640,247 Mar 14 09:53 PM Moore Carol SVP Reg. & Quality Mar 13 '24 Sale 2.02 20,619 41,553 490,623 Mar 14 09:49 PM Jensen Chrystal Chief Legal Officer Mar 13 '24 Sale 2.06 17,460 35,915 508,736 Mar 14 09:47 PM Jensen Chrystal Chief Legal Officer Mar 14 '24 Sale 1.97 17,824 35,192 490,912 Mar 14 09:47 PM Jayaraman Vivek K Chief Operating Officer Mar 13 '24 Sale 2.06 26,247 53,990 905,447 Mar 14 09:33 PM Jayaraman Vivek K Chief Operating Officer Mar 14 '24 Sale 1.97 26,794 52,902 878,653 Mar 14 09:33 PM Greenman William Mariner President and CEO Mar 14 '24 Sale 2.02 63,611 128,195 3,181,281 Mar 14 09:30 PM Greenman William Mariner President and CEO Mar 13 '24 Sale 2.06 62,315 128,182 3,244,892 Mar 14 09:30 PM CORASH LAURENCE M Chief Scientific Officer Mar 13 '24 Sale 2.06 14,067 28,936 2,354,100 Mar 14 09:22 PM CORASH LAURENCE M Chief Scientific Officer Mar 14 '24 Sale 1.97 14,360 28,352 2,339,740 Mar 14 09:22 PM Benjamin Richard J Chief Medical Officer Mar 13 '24 Sale 2.06 17,377 35,744 477,350 Mar 14 09:15 PM Benjamin Richard J Chief Medical Officer Mar 14 '24 Sale 1.97 17,738 35,022 459,612 Mar 14 09:15 PM Benjamin Richard J Chief Medical Officer Mar 08 '24 Sale 2.40 29,378 70,457 478,061 Mar 12 06:10 PM BJERKHOLT ERIC Director Dec 13 '23 Buy 1.62 10,000 16,200 142,133 Dec 13 05:55 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite